BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26070784)

  • 1. Genetic risk variants associated with in situ breast cancer.
    Campa D; Barrdahl M; Gaudet MM; Black A; Chanock SJ; Diver WR; Gapstur SM; Haiman C; Hankinson S; Hazra A; Henderson B; Hoover RN; Hunter DJ; Joshi AD; Kraft P; Le Marchand L; Lindström S; Willett W; Travis RC; Amiano P; Siddiq A; Trichopoulos D; Sund M; Tjønneland A; Weiderpass E; Peeters PH; Panico S; Dossus L; Ziegler RG; Canzian F; Kaaks R
    Breast Cancer Res; 2015 Jun; 17(1):82. PubMed ID: 26070784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium.
    Campa D; Kaaks R; Le Marchand L; Haiman CA; Travis RC; Berg CD; Buring JE; Chanock SJ; Diver WR; Dostal L; Fournier A; Hankinson SE; Henderson BE; Hoover RN; Isaacs C; Johansson M; Kolonel LN; Kraft P; Lee IM; McCarty CA; Overvad K; Panico S; Peeters PH; Riboli E; Sanchez MJ; Schumacher FR; Skeie G; Stram DO; Thun MJ; Trichopoulos D; Zhang S; Ziegler RG; Hunter DJ; Lindström S; Canzian F
    J Natl Cancer Inst; 2011 Aug; 103(16):1252-63. PubMed ID: 21791674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variants in FGFR2 and TNRC9 genes are associated with breast cancer risk in Pakistani women.
    Mazhar A; Jamil F; Bashir Q; Ahmad MS; Masood M; Tanvir I; Rashid N; Waheed A; Afzal MN; Tariq MA
    Mol Med Rep; 2016 Oct; 14(4):3443-51. PubMed ID: 27572905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic predisposition to in situ and invasive lobular carcinoma of the breast.
    Sawyer E; Roylance R; Petridis C; Brook MN; Nowinski S; Papouli E; Fletcher O; Pinder S; Hanby A; Kohut K; Gorman P; Caneppele M; Peto J; Dos Santos Silva I; Johnson N; Swann R; Dwek M; Perkins KA; Gillett C; Houlston R; Ross G; De Ieso P; Southey MC; Hopper JL; Provenzano E; Apicella C; Wesseling J; Cornelissen S; Keeman R; Fasching PA; Jud SM; Ekici AB; Beckmann MW; Kerin MJ; Marme F; Schneeweiss A; Sohn C; Burwinkel B; Guénel P; Truong T; Laurent-Puig P; Kerbrat P; Bojesen SE; Nordestgaard BG; Nielsen SF; Flyger H; Milne RL; Perez JI; Menéndez P; Benitez J; Brenner H; Dieffenbach AK; Arndt V; Stegmaier C; Meindl A; Lichtner P; Schmutzler RK; Lochmann M; Brauch H; Fischer HP; Ko YD; ; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Bogdanova NV; Dörk T; Lindblom A; Margolin S; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Chenevix-Trench G; ; Lambrechts D; Weltens C; Van Limbergen E; Hatse S; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Radice P; Peterlongo P; Bonanni B; Volorio S; Giles GG; Severi G; Baglietto L; McLean CA; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Simard J; Goldberg MS; Labrèche F; Dumont M; Kristensen V; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Kauppila S; Andrulis IL; Knight JA; Glendon G; Mulligan AM; Devillee P; Tollenaar RA; Seynaeve CM; Kriege M; Figueroa J; Chanock SJ; Sherman ME; Hooning MJ; Hollestelle A; van den Ouweland AM; van Deurzen CH; Li J; Czene K; Humphreys K; Cox A; Cross SS; Reed MW; Shah M; Jakubowska A; Lubinski J; Jaworska-Bieniek K; Durda K; Swerdlow A; Ashworth A; Orr N; Schoemaker M; Couch FJ; Hallberg E; González-Neira A; Pita G; Alonso MR; Tessier DC; Vincent D; Bacot F; Bolla MK; Wang Q; Dennis J; Michailidou K; Dunning AM; Hall P; Easton D; Pharoah P; Schmidt MK; Tomlinson I; Garcia-Closas M
    PLoS Genet; 2014 Apr; 10(4):e1004285. PubMed ID: 24743323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of genetic breast cancer susceptibility variants as prognostic factors.
    Fasching PA; Pharoah PD; Cox A; Nevanlinna H; Bojesen SE; Karn T; Broeks A; van Leeuwen FE; van't Veer LJ; Udo R; Dunning AM; Greco D; Aittomäki K; Blomqvist C; Shah M; Nordestgaard BG; Flyger H; Hopper JL; Southey MC; Apicella C; Garcia-Closas M; Sherman M; Lissowska J; Seynaeve C; Huijts PE; Tollenaar RA; Ziogas A; Ekici AB; Rauh C; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Andrulis IL; Ozcelik H; Mulligan AM; Glendon G; Hall P; Czene K; Liu J; Chang-Claude J; Wang-Gohrke S; Eilber U; Nickels S; Dörk T; Schiekel M; Bremer M; Park-Simon TW; Giles GG; Severi G; Baglietto L; Hooning MJ; Martens JW; Jager A; Kriege M; Lindblom A; Margolin S; Couch FJ; Stevens KN; Olson JE; Kosel M; Cross SS; Balasubramanian SP; Reed MW; Miron A; John EM; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Kauppila S; Burwinkel B; Marme F; Schneeweiss A; Sohn C; Chenevix-Trench G; ; Lambrechts D; Dieudonne AS; Hatse S; van Limbergen E; Benitez J; Milne RL; Zamora MP; Pérez JI; Bonanni B; Peissel B; Loris B; Peterlongo P; Rajaraman P; Schonfeld SJ; Anton-Culver H; Devilee P; Beckmann MW; Slamon DJ; Phillips KA; Figueroa JD; Humphreys MK; Easton DF; Schmidt MK
    Hum Mol Genet; 2012 Sep; 21(17):3926-39. PubMed ID: 22532573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study.
    Milne RL; Gaudet MM; Spurdle AB; Fasching PA; Couch FJ; Benítez J; Arias Pérez JI; Zamora MP; Malats N; Dos Santos Silva I; Gibson LJ; Fletcher O; Johnson N; Anton-Culver H; Ziogas A; Figueroa J; Brinton L; Sherman ME; Lissowska J; Hopper JL; Dite GS; Apicella C; Southey MC; Sigurdson AJ; Linet MS; Schonfeld SJ; Freedman DM; Mannermaa A; Kosma VM; Kataja V; Auvinen P; Andrulis IL; Glendon G; Knight JA; Weerasooriya N; Cox A; Reed MW; Cross SS; Dunning AM; Ahmed S; Shah M; Brauch H; Ko YD; Brüning T; ; Lambrechts D; Reumers J; Smeets A; Wang-Gohrke S; Hall P; Czene K; Liu J; Irwanto AK; Chenevix-Trench G; Holland H; ; ; Giles GG; Baglietto L; Severi G; Bojensen SE; Nordestgaard BG; Flyger H; John EM; West DW; Whittemore AS; Vachon C; Olson JE; Fredericksen Z; Kosel M; Hein R; Vrieling A; Flesch-Janys D; Heinz J; Beckmann MW; Heusinger K; Ekici AB; Haeberle L; Humphreys MK; Morrison J; Easton DF; Pharoah PD; García-Closas M; Goode EL; Chang-Claude J
    Breast Cancer Res; 2010; 12(6):R110. PubMed ID: 21194473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population.
    Jara L; Gonzalez-Hormazabal P; Cerceño K; Di Capua GA; Reyes JM; Blanco R; Bravo T; Peralta O; Gomez F; Waugh E; Margarit S; Ibañez G; Romero C; Pakomio J; Roizen G
    Breast Cancer Res Treat; 2013 Jan; 137(2):559-69. PubMed ID: 23225170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive analysis of polymorphic variants in steroid hormone and insulin-like growth factor-1 metabolism and risk of in situ breast cancer: Results from the Breast and Prostate Cancer Cohort Consortium.
    Barrdahl M; Canzian F; Gaudet MM; Gapstur SM; Trichopoulou A; Tsilidis K; van Gils CH; Borgquist S; Weiderpass E; Khaw KT; Giles GG; Milne RL; Le Marchand L; Haiman C; Lindström S; Kraft P; Hunter DJ; Ziegler R; Chanock SJ; Yang XR; Buring JE; Lee IM; Kaaks R; Campa D
    Int J Cancer; 2018 Mar; 142(6):1182-1188. PubMed ID: 29114882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-penetrance susceptibility variants and postmenopausal oestrogen receptor positive breast cancer.
    Özgöz A; İçduygu FM; Yükseltürk A; ŞamlI H; Öztürk KH; Başkan Z
    J Genet; 2020; 99():. PubMed ID: 32366738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer.
    Milne RL; Goode EL; García-Closas M; Couch FJ; Severi G; Hein R; Fredericksen Z; Malats N; Zamora MP; Arias Pérez JI; Benítez J; Dörk T; Schürmann P; Karstens JH; Hillemanns P; Cox A; Brock IW; Elliot G; Cross SS; Seal S; Turnbull C; Renwick A; Rahman N; Shen CY; Yu JC; Huang CS; Hou MF; Nordestgaard BG; Bojesen SE; Lanng C; Grenaker Alnæs G; Kristensen V; Børrensen-Dale AL; Hopper JL; Dite GS; Apicella C; Southey MC; Lambrechts D; Yesilyurt BT; Floris G; Leunen K; Sangrajrang S; Gaborieau V; Brennan P; McKay J; Chang-Claude J; Wang-Gohrke S; Radice P; Peterlongo P; Manoukian S; Barile M; Giles GG; Baglietto L; John EM; Miron A; Chanock SJ; Lissowska J; Sherman ME; Figueroa JD; Bogdanova NV; Antonenkova NN; Zalutsky IV; Rogov YI; Fasching PA; Bayer CM; Ekici AB; Beckmann MW; Brenner H; Müller H; Arndt V; Stegmaier C; Andrulis IL; Knight JA; Glendon G; Mulligan AM; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Meindl A; Heil J; Bartram CR; Schmutzler RK; Thomas GD; Hoover RN; Fletcher O; Gibson LJ; dos Santos Silva I; Peto J; Nickels S; Flesch-Janys D; Anton-Culver H; Ziogas A; Sawyer E; Tomlinson I; Kerin M; Miller N; Schmidt MK; Broeks A; Van 't Veer LJ; Tollenaar RA; Pharoah PD; Dunning AM; Pooley KA; Marme F; Schneeweiss A; Sohn C; Burwinkel B; Jakubowska A; Lubinski J; Jaworska K; Durda K; Kang D; Yoo KY; Noh DY; Ahn SH; Hunter DJ; Hankinson SE; Kraft P; Lindstrom S; Chen X; Beesley J; Hamann U; Harth V; Justenhoven C; ; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Hooning M; Hollestelle A; Oldenburg RA; Tilanus-Linthorst M; Khusnutdinova E; Bermisheva M; Prokofieva D; Farahtdinova A; Olson JE; Wang X; Humphreys MK; Wang Q; Chenevix-Trench G; ; ; Easton DF
    Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2222-31. PubMed ID: 21795498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics.
    Garcia-Closas M; Hall P; Nevanlinna H; Pooley K; Morrison J; Richesson DA; Bojesen SE; Nordestgaard BG; Axelsson CK; Arias JI; Milne RL; Ribas G; González-Neira A; Benítez J; Zamora P; Brauch H; Justenhoven C; Hamann U; Ko YD; Bruening T; Haas S; Dörk T; Schürmann P; Hillemanns P; Bogdanova N; Bremer M; Karstens JH; Fagerholm R; Aaltonen K; Aittomäki K; von Smitten K; Blomqvist C; Mannermaa A; Uusitupa M; Eskelinen M; Tengström M; Kosma VM; Kataja V; Chenevix-Trench G; Spurdle AB; Beesley J; Chen X; ; ; Devilee P; van Asperen CJ; Jacobi CE; Tollenaar RA; Huijts PE; Klijn JG; Chang-Claude J; Kropp S; Slanger T; Flesch-Janys D; Mutschelknauss E; Salazar R; Wang-Gohrke S; Couch F; Goode EL; Olson JE; Vachon C; Fredericksen ZS; Giles GG; Baglietto L; Severi G; Hopper JL; English DR; Southey MC; Haiman CA; Henderson BE; Kolonel LN; Le Marchand L; Stram DO; Hunter DJ; Hankinson SE; Cox DG; Tamimi R; Kraft P; Sherman ME; Chanock SJ; Lissowska J; Brinton LA; Peplonska B; Klijn JG; Hooning MJ; Meijers-Heijboer H; Collee JM; van den Ouweland A; Uitterlinden AG; Liu J; Lin LY; Yuqing L; Humphreys K; Czene K; Cox A; Balasubramanian SP; Cross SS; Reed MW; Blows F; Driver K; Dunning A; Tyrer J; Ponder BA; Sangrajrang S; Brennan P; McKay J; Odefrey F; Gabrieau V; Sigurdson A; Doody M; Struewing JP; Alexander B; Easton DF; Pharoah PD
    PLoS Genet; 2008 Apr; 4(4):e1000054. PubMed ID: 18437204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype.
    Han W; Woo JH; Yu JH; Lee MJ; Moon HG; Kang D; Noh DY
    Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):793-8. PubMed ID: 21415360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
    Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
    BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of breast cancer susceptibility loci in Chinese women.
    Long J; Shu XO; Cai Q; Gao YT; Zheng Y; Li G; Li C; Gu K; Wen W; Xiang YB; Lu W; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2357-65. PubMed ID: 20699374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low penetrance breast cancer predisposition SNPs are site specific.
    Mcinerney N; Colleran G; Rowan A; Walther A; Barclay E; Spain S; Jones AM; Tuohy S; Curran C; Miller N; Kerin M; Tomlinson I; Sawyer E
    Breast Cancer Res Treat; 2009 Sep; 117(1):151-9. PubMed ID: 19005751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNRC9 rs12443621 and FGFR2 rs2981582 polymorphisms and breast cancer risk.
    Chen Y; Shi C; Guo Q
    World J Surg Oncol; 2016 Feb; 14(1):50. PubMed ID: 26911390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation.
    Ghoussaini M; French JD; Michailidou K; Nord S; Beesley J; Canisus S; Hillman KM; Kaufmann S; Sivakumaran H; Moradi Marjaneh M; Lee JS; Dennis J; Bolla MK; Wang Q; Dicks E; Milne RL; Hopper JL; Southey MC; Schmidt MK; Broeks A; Muir K; Lophatananon A; Fasching PA; Beckmann MW; Fletcher O; Johnson N; Sawyer EJ; Tomlinson I; Burwinkel B; Marme F; Guénel P; Truong T; Bojesen SE; Flyger H; Benitez J; González-Neira A; Alonso MR; Pita G; Neuhausen SL; Anton-Culver H; Brenner H; Arndt V; Meindl A; Schmutzler RK; Brauch H; Hamann U; Tessier DC; Vincent D; Nevanlinna H; Khan S; Matsuo K; Ito H; Dörk T; Bogdanova NV; Lindblom A; Margolin S; Mannermaa A; Kosma VM; ; Wu AH; Van Den Berg D; Lambrechts D; Floris G; Chang-Claude J; Rudolph A; Radice P; Barile M; Couch FJ; Hallberg E; Giles GG; Haiman CA; Le Marchand L; Goldberg MS; Teo SH; Yip CH; Borresen-Dale AL; ; Zheng W; Cai Q; Winqvist R; Pylkäs K; Andrulis IL; Devilee P; Tollenaar RA; García-Closas M; Figueroa J; Hall P; Czene K; Brand JS; Darabi H; Eriksson M; Hooning MJ; Koppert LB; Li J; Shu XO; Zheng Y; Cox A; Cross SS; Shah M; Rhenius V; Choi JY; Kang D; Hartman M; Chia KS; Kabisch M; Torres D; Luccarini C; Conroy DM; Jakubowska A; Lubinski J; Sangrajrang S; Brennan P; Olswold C; Slager S; Shen CY; Hou MF; Swerdlow A; Schoemaker MJ; Simard J; Pharoah PD; Kristensen V; Chenevix-Trench G; Easton DF; Dunning AM; Edwards SL
    Am J Hum Genet; 2016 Oct; 99(4):903-911. PubMed ID: 27640304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of functional germline variants in APOBEC3 and driver genes on breast cancer risk in Moroccan study population.
    Marouf C; Göhler S; Filho MI; Hajji O; Hemminki K; Nadifi S; Försti A
    BMC Cancer; 2016 Feb; 16():165. PubMed ID: 26920143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 women.
    Barrdahl M; Canzian F; Joshi AD; Travis RC; Chang-Claude J; Auer PL; Gapstur SM; Gaudet M; Diver WR; Henderson BE; Haiman CA; Schumacher FR; Le Marchand L; Berg CD; Chanock SJ; Hoover RN; Rudolph A; Ziegler RG; Giles GG; Baglietto L; Severi G; Hankinson SE; Lindström S; Willet W; Hunter DJ; Buring JE; Lee IM; Zhang S; Dossus L; Cox DG; Khaw KT; Lund E; Naccarati A; Peeters PH; Quirós JR; Riboli E; Sund M; Trichopoulos D; Prentice RL; Kraft P; Kaaks R; Campa D
    Hum Mol Genet; 2014 Oct; 23(19):5260-70. PubMed ID: 24895409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel and known genetic variants for male breast cancer risk at 8q24.21, 9p21.3, 11q13.3 and 14q24.1: results from a multicenter study in Italy.
    Silvestri V; Rizzolo P; Scarnò M; Chillemi G; Navazio AS; Valentini V; Zelli V; Zanna I; Saieva C; Masala G; Bianchi S; Manoukian S; Barile M; Pensotti V; Peterlongo P; Varesco L; Tommasi S; Russo A; Giannini G; Cortesi L; Viel A; Montagna M; Radice P; Palli D; Ottini L
    Eur J Cancer; 2015 Nov; 51(16):2289-95. PubMed ID: 26248686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.